These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Muir KW; Lees KR Stroke; 1995 Jul; 26(7):1183-8. PubMed ID: 7541572 [TBL] [Abstract][Full Text] [Related]
3. Pilot study to determine the hemodynamic safety and feasibility of magnesium sulfate infusion in children with severe traumatic brain injury. Natale JE; Guerguerian AM; Joseph JG; McCarter R; Shao C; Slomine B; Christensen J; Johnston MV; Shaffner DH Pediatr Crit Care Med; 2007 Jan; 8(1):1-9. PubMed ID: 17251875 [TBL] [Abstract][Full Text] [Related]
4. Results of the MRI substudy of the intravenous magnesium efficacy in stroke trial. Kidwell CS; Lees KR; Muir KW; Chen C; Davis SM; De Silva DA; Weir CJ; Starkman S; Alger JR; Saver JL; Stroke; 2009 May; 40(5):1704-9. PubMed ID: 19299636 [TBL] [Abstract][Full Text] [Related]
5. Preventive effect of continuous cisternal irrigation with magnesium sulfate solution on angiographic cerebral vasospasms associated with aneurysmal subarachnoid hemorrhages: a randomized controlled trial. Yamamoto T; Mori K; Esaki T; Nakao Y; Tokugawa J; Watanabe M J Neurosurg; 2016 Jan; 124(1):18-26. PubMed ID: 26230471 [TBL] [Abstract][Full Text] [Related]
6. A randomized, double-blind, placebo-controlled pilot trial of intravenous magnesium sulfate in acute stroke. Muir KW; Lees KR Ann N Y Acad Sci; 1995 Sep; 765():315-6. PubMed ID: 7486627 [No Abstract] [Full Text] [Related]
7. The safety and feasibility of continuous intravenous magnesium sulfate for prevention of cerebral vasospasm in aneurysmal subarachnoid hemorrhage. Yahia AM; Kirmani JF; Qureshi AI; Guterman LR; Hopkins LN Neurocrit Care; 2005; 3(1):16-23. PubMed ID: 16159090 [TBL] [Abstract][Full Text] [Related]
8. Paramedic Initiation of Neuroprotective Agent Infusions: Successful Achievement of Target Blood Levels and Attained Level Effect on Clinical Outcomes in the FAST-MAG Pivotal Trial (Field Administration of Stroke Therapy - Magnesium). Shkirkova K; Starkman S; Sanossian N; Eckstein M; Stratton S; Pratt F; Conwit R; Hamilton S; Sharma L; Liebeskind D; Restrepo L; Valdes-Sueiras M; Saver JL; Stroke; 2017 Jul; 48(7):1901-1907. PubMed ID: 28583999 [TBL] [Abstract][Full Text] [Related]
9. Prehospital use of magnesium sulfate as neuroprotection in acute stroke. Saver JL; Starkman S; Eckstein M; Stratton SJ; Pratt FD; Hamilton S; Conwit R; Liebeskind DS; Sung G; Kramer I; Moreau G; Goldweber R; Sanossian N; N Engl J Med; 2015 Feb; 372(6):528-36. PubMed ID: 25651247 [TBL] [Abstract][Full Text] [Related]
10. Dose finding study of intravenous magnesium sulphate in transient focal cerebral ischemia in rats. Westermaier T; Zausinger S; Baethmann A; Schmid-Elsaesser R Acta Neurochir (Wien); 2005 May; 147(5):525-32; discussion 532. PubMed ID: 15838594 [TBL] [Abstract][Full Text] [Related]
12. A randomized trial comparing the pharmacology of magnesium sulfate when used to treat severe preeclampsia with serial intravenous boluses versus a continuous intravenous infusion. Easterling T; Hebert M; Bracken H; Darwish E; Ramadan MC; Shaarawy S; Charles D; Abdel-Aziz T; Nasr AS; Safwal SM; Winikoff B BMC Pregnancy Childbirth; 2018 Jul; 18(1):290. PubMed ID: 29976161 [TBL] [Abstract][Full Text] [Related]
13. Intravenous infusion of magnesium sulfate and regional redistribution of fetal blood flow during maternal hemorrhage in late-gestation gravid ewes. Moon PF; Ramsay MM; Nathanielsz PW Am J Obstet Gynecol; 1999 Dec; 181(6):1486-94. PubMed ID: 10601933 [TBL] [Abstract][Full Text] [Related]
14. Intravenous and intramuscular magnesium sulphate regimens in severe pre-eclampsia. Chissell S; Botha JH; Moodley J; McFadyen L S Afr Med J; 1994 Sep; 84(9):607-10. PubMed ID: 7839282 [TBL] [Abstract][Full Text] [Related]
15. Remacemide hydrochloride: a double-blind, placebo-controlled, safety and tolerability study in patients with acute ischemic stroke. Dyker AG; Lees KR Stroke; 1999 Sep; 30(9):1796-801. PubMed ID: 10471426 [TBL] [Abstract][Full Text] [Related]
16. Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage (IMASH): a randomized, double-blinded, placebo-controlled, multicenter phase III trial. Wong GK; Poon WS; Chan MT; Boet R; Gin T; Ng SC; Zee BC; Stroke; 2010 May; 41(5):921-6. PubMed ID: 20378868 [TBL] [Abstract][Full Text] [Related]
17. Magnesium repletion and its effect on potassium homeostasis in critically ill adults: results of a double-blind, randomized, controlled trial. Hamill-Ruth RJ; McGory R Crit Care Med; 1996 Jan; 24(1):38-45. PubMed ID: 8565536 [TBL] [Abstract][Full Text] [Related]
18. Safety, tolerability, and pharmacokinetics of the N-methyl-D-aspartate antagonist dextrorphan in patients with acute stroke. Dextrorphan Study Group. Albers GW; Atkinson RP; Kelley RE; Rosenbaum DM Stroke; 1995 Feb; 26(2):254-8. PubMed ID: 7831698 [TBL] [Abstract][Full Text] [Related]
19. Maternal adverse effects with different loading infusion rates of antenatal magnesium sulphate for preterm fetal neuroprotection: the IRIS randomised trial. Bain ES; Middleton PF; Yelland LN; Ashwood PJ; Crowther CA BJOG; 2014 Apr; 121(5):595-603. PubMed ID: 24387624 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic intravenous magnesium sulfate for treatment of aneurysmal subarachnoid hemorrhage: a randomized, placebo-controlled, clinical study. Westermaier T; Stetter C; Vince GH; Pham M; Tejon JP; Eriskat J; Kunze E; Matthies C; Ernestus RI; Solymosi L; Roosen K Crit Care Med; 2010 May; 38(5):1284-90. PubMed ID: 20228677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]